Joint Formulary & PAD

Committees : SASH DTG

Profiles (0)

No records returned.

Committee Recommendations (28)

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Aptamil Pepti 1  for cow's milk allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Althera for cows milk protein allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Nutramigen Puramino for multiple food allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Alfamino for multiple food allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Althera for multiple food allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Nutramigen Puramino for cows milk protein allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary Alfamino for cows milk protein allergy.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Neocate Junior for cows milk protein allergy

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Nutrini Peptisorb Energy for enteral nutrition in paediatrics.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Peptamen Junior Advance - Enteral nutrition (tube feeding).

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Compact Paediatric enteral nutrition.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Fresubin Plant-Based Drink in malnutrition.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for calogen for malnutrition.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Fortini 1.0 Multifibre for malnutrition in children.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Compact Multifibre for malnutrition in children.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Fortini Creamy Fruit Multi Fibre for malnutrition in children.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Fortini Smoothie Multifibre for malnutrition in children.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Aptamil Nutriprem 1 for pre-term and low birthweight infants

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Botulinum toxin type A injection for preoperative abdominal wall relaxation in complex hernia repairs.

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formulary for Aptamil Hydrolysed Nutriprem for pre-term and low birthweight infants

16 Dec 25

The Surrey and Sussex NHS Trust Drugs and Therapeutics Group has agreed addition to the formularyfor OpitiFibre sachets in paediatrics for fibre supplementation

17 Nov 25

The Surrey and Sussex NHS Healthcare Drug and Therapeutics Group agreed to the addition of benztropine injection for treatement of acute dystonia and drug induced dystonic reactions in place of  procyclidine.

21 Oct 25

The SASH Drugs and Therapeutics Group will upload final minutes of the DTG to this page each month. Please contact the Formulary Development Pharmacist at sash.pharmacyformulary@nhs.net for previous minutes.

21 Oct 25

The Surrey and Sussex NHS Healthcare Drug and Therapeutics Group agreed to the addition of sucralfate enema for the treatment of radiation proctits

16 Sep 25

Approved for adults only.

15 Jul 25

The SASH Drugs and Therapeutics Group approved the use of this drug and indication for use in paediatrics by ophthalmic consultants only.

17 Jun 25

SASH DTG agreed the use of Oralieve gel and Saliveze spray as options for dry mouth.

05 Jun 24

Indication:  Rib fracture (off-label). Approved for use on advice of pain team, ICU, anaesthetic, surgical, orthopaedic and ED consultants only

It is indicated in the following situations:

  1. First line for elderly patients (age >65) eg those with high risk systemic side-effects from opiates, dementia and delirium, falls causing chest trauma.
  2. First line for patients with a high chest injury score prior to waiting for regional infusion via CEPOD theatre if likelihood of delays.
  3. First line for patients not suitable for regional procedure eg dementia with aggression, anterior/ sternal fractures or high risk due to anticoagulation therapy.
  4. Second line for physically well patients whose pain is not well controlled with other analgesia.
  5. First line for patients where opioids are not appropriate or need to be reduced to reduce risk of respiratory depression and other side effects. 

Supply for maximum of 2 weeks